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PSG7
POSTOPERATIVE PAIN RELIEF, INTERFERENCE 
WITH ACTIVITIES, AND SATISFACTION: 
PRELIMINARY RESULTS
Strassels S1, Chen C2, Carr D1, McDonagh M1, Gouveia W1, 
Wurm H1
1New England Medical Center, Boston, MA, USA; 2Searle 
Pharmaceuticals, Skokie, IL, USA
Postoperative pain is suboptimally controlled for many
people; however, limited information is available about
pain from the patient’s perspective. OBJECTIVES: A
purpose of this observational pilot study was to describe
patient’s postoperative pain relief and their satisfaction
with their care after common abdominal or orthopedic
surgical procedures. METHODS: Within 24 hours be-
fore discharge from the hospital after total abdominal
hysterectomy (TAH), or total hip or knee replacement
(THR, TKR), patients completed a new survey that in-
cluded a modified version of the American Pain Society
(APS) Quality Improvement Questionnaire. Percent pain
relief and pain-related interference with activities were
rated on a 0 (0% relief, no interference)–10 (100% relief,
maximum interference) analog scale. Satisfaction with
pain treatment was rated on a six-point Likert scale.
Data were collected between August and November
1999. RESULTS: Mean percent pain relief from analge-
sics was at least 70% for all persons in each surgical
group and overall. On average, pain interfered most with
sleep (5.4/10) for TAH and THR patients, and 6.7/10 for
TKR patients, and with walking ability for THR (5.0/10)
and TKR (5.8/10) patients. Of TAH patients, 42.9% re-
ported being slightly dissatisfied, and 57.1% reported be-
ing satisfied with their pain care. All THR patients and
more than 82% of TKR patients were satisfied or very
satisfied with their pain treatment. CONCLUSION: Al-
though pain interfered with sleep and other activities,
most patients were satisfied with their pain care. Pain lev-
els and pain-related interference with activities may be re-
lated to suboptimal analgesic doses or dosing frequency.
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LONG-TERM OUTCOMES AND RESOURCE USE 
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Myomectomy is the most commonly performed proce-
dure for women with large fibroids who want to preserve
their uterus. Since myomectomy is associated with a 15–
30% rate of fibroid recurrence, a systematic assessment
of long-term resource use is critical for evaluation but to
date no comprehensive analyses have been performed.
OBJECTIVE: To evaluate the long-term outcomes and
cost of myomectomy through retrospective claims data
analysis. METHODS: The study was performed using
the MEDSTAT MarketScan private pay fee-for-service
database for the years 1995, 1996, and 1997. Patients
were selected for analysis based on the presence of ICD-
9-CM procedure and/or CPT-4 codes associated with
myomectomy. In addition, diagnosis of uterine fibroids
and related symptoms for these patients were confirmed
through ICD-9-CM diagnosis codes. Inpatient, outpa-
tient, physician, and pharmacy data for all three years
were combined into a single file using unique patient
identifiers. All cost data were converted to 1997 dollars.
RESULTS: A total of 3,730 women, between the ages of
19 and 62, were available for analysis. Of these, 39%
had an inpatient admission while the remaining only had
outpatient procedures. The estimated cost of an abdomi-
nal myomectomy procedure was $7,551 and that of a
vaginal myomectomy was $3,136. Preliminary analysis
indicates that at least 8% of the women had an addi-
tional procedure within a year and a higher percentage in
subsequent years. There were also a high number of fi-
broid-related outpatient visits and some prescription medi-
cation use. CONCLUSION: The high number of repeat
procedures, outpatient visits, and prescription medica-
tion add significantly to total cost and highlight the im-
portance of assessing overall health care utilization. This
comprehensive analysis facilitates the systematic evalua-
tion of myomectomy with emerging alternative treat-
ments for uterine fibroids.
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Indications for the use of coronary stents are evolving
and their optimal place in therapy remains to be defined.
OBJECTIVE: The purpose of this analysis was to com-
pare the one-year clinical and economic outcomes of per-
cutaneous transluminal coronary angioplasty (PTCA)
with or without the use of stents. METHODS: This ret-
rospective database analysis from 60 US academic medi-
cal centers in 1996 and 1997 included 27,020 patients
that either did (n  13,254) or did not (n  13,766) re-
ceive stents in conjunction with PTCA. Outcomes of in-
terest included in-hospital mortality (both on sentinel
and readmission visits), readmission rates, revasculariza-
tion procedures, length of stay, and the cost of sentinel
and readmission hospitalizations. RESULTS: The median
hospitalization cost for the stent group was about $1409
higher than for the no-stent group, even though they had
similar lengths of stay (4.3 days vs. 4.5 days respectively,
P  0.001). While mortality rates on readmissions (0.9%
stent vs. 0.8% no-stent, p  NS) did not differ, stent
placement during the sentinel event was associated with
